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Flow cytometric analysis of live epithelial cell populations harvested from colon organoids, TWs, Colon Chips, and human colonic tissue confirmed that there was little goblet cell differentiation in the TW and organoid cultures, whereas ~15% of the epithelial cells differentiated into goblet cell in the Colon Chip, which similar to the percentage of goblet cells we measured in human colon tissue samples (~10-30% depending on the donor; Figure 2C ,D, Supplementary Figure 4A ). Furthermore, the MUC2+ cells on the Colon Chip exhibited the typical goblet cell shape with apical location of mucus granules as observed in vivo (Figure 2E ) 26 , as well as a similar surface morphology when analyzed by scanning electron microscopy ( Figure 2F) 28 .
Importantly, despite supporting spontaneous goblet cell differentiation, the Colon Chip cultures were simultaneously able to maintain a proliferative cell subpopulation at levels similar to those present in the organoid and TW cultures (Supplementary Figure 4B) . While past work has shown that some goblet cell differentiation can be induced in TW cultures and organoids by replacing the stem cell expansion medium with differentiation medium 27, 29, 30 , these cultures cease proliferating and are short-lived. Thus, the Colon Chip effectively provided an environment for goblet cell differentiation under conditions in which proliferative cells also remain present as occurs in human colon in vivo, while other culture models do not.
Analysis of intestinal mucus accumulation and bilayer structure in living cultures
Given the spontaneous differentiation of large numbers of goblet cells in the Colon Chip that produce MUC2, which is the main mucin in colonic mucus, we next investigated if a physiologically relevant mucus bilayer forms on-chip. The existence of a mucus layer within the lumen of the apical epithelial channel was suggested by the appearance of increasing opacity of the Colon Chip over time when viewed from above by light microscopy (Supplementary Figure   2B , C). Importantly, because the microfluidic Organ Chip is optically clear and has defined linear channel geometries (Figure 1A) , we were able to develop a method to visualize live cultures in 10 cross section across the entire channel. This was accomplished by slicing ~ 2 mm of the PDMS material away from the sides of the upper and lower channels, then turning the device 90° on its side and analyzing it using Dark Field (DF) microscopy ( Figure 3A-C, Supplementary Figure   5A , B). Using this method, we detected the formation of a highly scattering layer above the cells that was well-developed by 1 week and when we analyzed the same chips over time, it continued to increase in height over the following week (Figure 3B) . This layer stained positively for MUC2 and resided on top of the apical F-actin-rich brush border of the epithelium (Figure 3C) , confirming that this material that accumulated over time in the Colon Chip is indeed a thick mucus layer. Fixation of intestine tissue with paraformaldehyde has been shown to produce a compression artifact (thinning of the layer) and disrupt the inner layer 17, 31 ; thus, an important advantage of this method is that it enables the in situ study of mucus development in its native state over an extended period of time in living cultures.
One of the unique properties of human colonic mucus is its bilayer structure, which is characterized by an inner layer that is impenetrable by bacteria and an outer penetrable mucus layer that is normally populated by commensal microbes. This feature of the mucus layer has been previously probed in tissue explants utilizing fluorescent 1 µm diameter microbeads to mimic bacteria 20 . When we flowed similar fluorescent microbeads through the lumen of the epithelial channel and allowed them to settle, we observed a bead-free region approximately 200 µm in height above the apical membrane of the epithelial cells at days 7 and 14 (Figure 3D , E), which is similar to the thickness of the dense impenetrable inner mucus layer observed in human colon tissue explants using this method 20 . The spread of the beads trapped in the mucus above the impenetrable layer corresponded to the penetrable outer mucus layer ( Figure   3D , E). When we quantified the total height of the mucus layer (both inner and outer layers) formed on chip, we found that it reached ~570 µm by day 14 (Figure 3E ). Scanning electron microscopic analysis of a cross-section of the Colon Chip also revealed the presence of a 11 fibrous network within the thick mucus layer in tight contact with the upper surface of the epithelium (Figure 3F) , which again is similar to what has been observed in tissue explants analyzed using lectin staining 32 . Thus, the microfluidic human Colon Chip is the first in vitro method to support spontaneous accumulation of a mucus layer in tight apposition to the apical surface of a cultured human colonic epithelium that replicates the thickness and unique bilayer properties displayed by human colonic mucus in vivo.
Modeling the response of colonic epithelium to PGE2 on-chip
Prostaglandin E2 (PGE2) has been reported to be elevated in patients with ulcerative colitis, and it appears to contribute to healing of intestinal ulcers by increasing cell proliferation and altering mucus physiology [9] [10] [11] [13] [14] [15] . To explore if the human Colon Chip method can be used to study this response in vitro, we perfused PGE2 (1.4 nM) through the basal channel from day 2 to 8. This 6-day exposure to PGE2 resulted in a 4.5-fold increase in proliferating cells compared to control chips, as measured by EdU incorporation (Figure 4A) , as well as a 1.6-fold increase in MUC2+ cells ( Figure 4B) . The rise in EdU incorporation is consistent with reports that PGE2 promotes cell proliferation and is essential for wound healing [9] [10] [11] .
In these studies, we noticed that the PGE2-treated chips developed blockage of the apical channel preventing fluid flow, suggesting that there also might be increased mucus production. This was surprising because the PGE2-treated Colon Chips appeared to contain less light-obscuring material compared to control Chips when imaged from above by bright field microscopy ( Figure 4C) , which stands in direct contrast to the increased opacity associated with the mucus layer development we observed in our earlier studies. Past animal and tissue explant studies exploring the effect of PGE2 on mucus production have produced contradictory results. Short term PGE2 treatment has been reported to increase colonic mucus accumulation in murine intestinal loop studies and mouse proximal colon explants [13] [14] [15] , but no increase in 12 mucus secretion could be detected in response to PGE2 treatment in isolated human colonic crypts 16 or distal colon mouse tissue explants 15 .
Thus, we set out to evaluate the short-term effect of PGE2 on mucus layer height using the human Colon Chip. Short term (4 h) treatment of the Colon Chip with PGE2 resulted in an increase in mucus height by 321.8 ± 44.3 µm, which is equivalent to a ~2-fold increase compared to control chips (Figure 4D, Supplementary Figure 6A ). Interestingly, however, there did not appear to be an associated increase in the total amount of mucins when quantified using an alcian blue-binding assay (Supplementary Figure 6B) . This result suggests that the increase in height we detected was not due to secretion of more mucin materials, but rather to swelling of the pre-existing mucus.
While PGE2 has a multitude of functions in intestinal physiology, it plays an important role in the regulation of fluid secretion via ion transport 12 . Because mucus production has been shown to depend on fluid secretion in mouse small intestine 33, 34 , we tested if this property of PGE2 was responsible for its ability to rapidly increase mucus height. PGE2-induced fluid secretion can be blocked by inhibiting ion channels 12 , and so we pretreated the human Colon Chip with a combination of 3 different ion channel inhibitors, CFTRinh-172, XE-991, and bumetanide, which are chemical inhibitors of the cystic fibrosis transmembrane conductance regulator (CFTR), KV7 (KCNQ) voltage-gated potassium channel, and NKCC1 Na-K-Cl cotransporter, respectively, before infusing PGE2. The combination of the 3 different ion channel inhibitors led to a significant reduction in the PGE2-induced increase in mucus height confirming the importance of ion transport in this hydration response (Figure 4E,   Supplementary Figure 7) .
To analyze the effects of each ion channel inhibitor individually, different Colon Chips were pre-treated with each of these ion channel inhibitors before exposing them to PGE2.
Suppression of the CFTR and Kv7 K+ channel activity had no significant effect, however, 13 inhibition of the basolateral NKCC1 Na-K-Cl cotransporter with bumetanide significantly reduced PGE2-induced mucus layer height on-chip (Figure 4E, Supplementary Figure 7) . None of these channel inhibitors altered total mucin content ( Figure 4F) . Thus, the increase in mucus height we observed upon short term exposure to PGE2 is largely due to ion and fluid secretioninduced swelling of pre-existing mucus.
As the structural integrity of the colonic mucus layer is an essential part of the intestinal barrier, local changes in mucin organization or concentration due to swelling could affect structural properties of the mucus as well. Notably, the inner impenetrable mucus layer was preserved during PGE2-induced swelling of the mucus layer (Figure 4G, Supplementary   Figure 8 ). Furthermore, when we exposed the mucus layers of control and PGE2-treated Colon Chips to increasing flow velocities, we found that the mucus layers in both chips exhibited similar bending angles, and hence, similar material responses to shear stress ( Supplementary   Figure 9 , Supplementary Video 1). This suggests that despite changes in hydration state of the mucus layer, its gross structural integrity was maintained.
DISCUSSION
Although the structure and function of the human colonic mucus bilayer is highly relevant for intestinal pathophysiology, previous investigation of its properties could only be carried in short-term (< 1 day) ex vivo tissue explants. This is because cultured human colonic epithelial cells do not produce a thick mucus layer with a normal bilayer structure in organoids, TW cultures, or any other in vitro model 17 . In contrast, in the present study, we showed that a microfluidic 2-channel human Colon Chip enables long-term culture of primary human colonic epithelial cells under dynamic flow conditions. Moreover, this system supports the spontaneous differentiation of large numbers of mucus-producing goblet cells at similar levels to those observed in human colon in vivo, while still maintaining a healthy subpopulation of proliferative cells. Importantly, under these culture conditions, the human colonic epithelial cells produced a 14 mucus bilayer containing an impenetrable layer closely apposed to the apical surface of the epithelium, directly overlaid by a penetrable mucus layer, with a total thickness of 500-600 m, which is similar to that seen in living human colon in vivo 20 . Thus, this is the first culture method to recapitulate the development of a thick human colonic mucus layer with its unique bilayer structure.
Another novel feature of the human Colon Chip method is that the optical clarity of the microfluidic device allows live non-invasive visual analysis of mucus accumulation and physiology over time in culture. The dynamic changes in mucus layer thickness induced in vivo by the inflammatory mediator, PGE2, could be replicated, quantified, and analyzed on-chip.
This revealed that rapid changes in mucus layer height after short term exposure to PGE2 are primarily mediated by altering the hydration state of pre-existing mucus via ion secretion through NKCC1, and not due to additional mucus secretion. Furthermore, our data indicate that colonic mucus may be able to undergo significant expansion without losing barrier-function or structural stability, highlighting the remarkable characteristics of this physiologically important structure.
These findings demonstrate the usefulness of the Colon Chip as an in vitro tool for evaluation of mucus structure and function, which could advance our understanding of mucus physiology in disease contexts. Considering recent advances in bacterial co-cultures in intestinal microfluidic models 23, 24, 35, 36 , this microfluidic Colon Chip lined by patient-derived colonic epithelial cells may also facilitate development of new therapeutics or probiotics that modulate the mucus barrier, as well as provide a novel testbed for personalized medicine.
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MATERIALS AND METHODS

Isolation of human colon epithelial cells
Transwell insert cultures
Transwell® culture inserts (TWs; 6.5 mm) with 0.4 µm pore polyester membrane (3470, Corning) were coated as described above for the chip, and seeded with colon organoids fragments at the same density (6 x 10 5 cells cm -2 ) on the top side of the TWs in stem cell expansion medium supplemented with 10 μM Y-27632, and the same medium was added to the bottom chamber. As with the chips, the TWs were incubated overnight at 37C under 5% CO2, and the following day, the TW was washed once with stem cell expansion medium before adding 1 ml stem cell expansion medium on the basal side and 250 μl of HBSS with calcium and magnesium supplemented with 100 μg ml -1 primocin to the apical side; medium was changed every 2 days thereafter.
Organoid cultures
Colon organoid fragments were resuspended in growth factor-reduced Matrigel at 1 x 10 6 cells ml -1 and plated in 24 or 48 well plates (50 or 10 μl drops/well, respectively), and covered with stem cell expansion medium supplemented with 10 μM Y-27632 (500 μl or 200 μl/ well, respectively). Stem cell expansion medium was changed every 2 days thereafter. 
Immunofluorescent microscopy
PGE2 treatment
For long-term PGE2 studies, the basal channel of the Colon Chips was perfused with stem cell expansion medium 1.4 nM PGE2 (P5640, Sigma) for 6 days, starting at day 2. To quantify cell proliferation, 10 µM EdU (C10645, Invitrogen) was perfused through both channels of the chip for 18 hours prior to enzymatically detaching cells on day 8 and carry out flow cytometric analysis. Short term treatment with PGE2 and ion channel inhibitors was performed at 7 days after monolayer formation. In short, Colon Chips were perfused with medium (stem cell expansion medium basally, HBSS apically) containing 50 µM CFTRinh-172 (S7139, Selleckchem), 20 µM XE-991 Dihydrochloride (20010, tocris), 100 µM Bumetanide (S1287, Selleckchem), or combination of the 3 inhibitors at 60 µl h -1 for 4h, followed by side view imaging to determine the baseline height of the mucus layer prior to PGE2 treatment . After baseline side view imaging, the chips were then switched to co-treatment with 1.4 nM PGE2 (basal channel) and the respective ion channel inhibitors (apically and basally). After 4h of cotreatment with inhibitors and PGE2, side view imaging was performed to determine the swelling of the mucus layer.
Scanning Electron Microscopy
To visualize the epithelium and mucus layer on-chip, SEM analysis was carried out using Colon Chips that had a top channel that was not irreversibly bonded to the membrane, 22 which allowed the device to be dismantled manually as describe previously 39 . Cells were fixed with 4% PFA (157-4, Electron Microscopy Sciences) and 2.5% glutaraldehyde (G7776; Sigma) in DPBS and incubated in 0.5% osmium tetroxide (19152, Electron Microscopy Sciences) in 0.1 M sodium cacodylate buffer (pH 7.4) before serial dehydration in ethanol. Samples were then dried using a critical point drier and imaged using field emission SEM (Hitachi S-4700).
For cross sectional SEM images, Colon Chips were fixed with 2.5% Glutaraldehyde in 0.1 M Phosphate Buffer (P5244, Sigma) overnight and washed with water before being flashfrozen in liquid nitrogen. Frozen chips were sectioned into 5 mm cross sections on dry ice, lyophilized, mounted on aluminum pin mounts with conductive carbon tape, sputter-coated with gold, and examined with a Tescan Vega3 GMU scanning electron microscope.
Analysis of inner and outer mucus layer
Cells in the Colon Chips were stained for live cells by perfusing both channel for 30 min with medium (stem cell expansion medium basally, HBSS apically) containing 10 µM Calcein AM (C3100MP, Invitrogen) (200 µl h -1 ); the medium perfused through the apical channel also contained 1 µm FluoSpheres™ Carboxylate-Modified Microspheres (70 µl ml -1 ; F13083, Invitrogen). Colon Chips were incubated under static conditions for 40 min to allow the fluorescent beads to settle, and then z-stack images of 2-3 areas of each chip were collected using a Leica SP5 confocal microscope. Calcein AM was imaged with a 488 nm Argon laser, and beads were visualized using the multiphoton laser at 1000 nm. Confocal z-stacks were reconstructed and analyzed using IMARIS software (Bitplane). To determine the thicknesses of the inner and outer mucus layers, a Gaussian distribution was fit to the data using Matlab and height of the outer layer was determined using the middle 90% of the Gaussian distribution of the beads. The inner layer was set as the distance between the apical cell surface and the lower bound of the outer layer.
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Shear stress deformation assay
Increasing flow rates were applied to the Colon Chips using a Fusion Touch Syringe Pump. Side view images were acquired by transmitted light microscopy and movies were generated during flow and stop cycles of the pump at 1.6 ml h -1 , 6 ml h -1 , 10 ml h -1 . Images were then analyzed using Fiji software by tracing movement of mucus strains while flow was applied compared to the final position after flow was stopped. Angle between flow and no flow was calculated (great angle equals great deformation).
Drawings
All drawings were created with BioRender.
Alciann blue mucin assay
Mucus was loosened from the apical surfaces of the colon chips by reducing disulfide bonds with 250 mM Tris (2-carboxyethyl) phosphine (C4706, Sigma-Aldrich). After 1h incubation, the mucus layer was mechanically separated by washing the apical channel with phosphate buffered saline (PBS). Samples were frozen, lyophilized overnight and reconstituted in PBS. Total mucous amount was determined using an alcian blue colorimetric assay adapted from Hall et al (1980) 40 . Briefly, a standard curve was created using serial dilutions of submaxillary gland mucin (Sigma) ranging from 0 g ml -1 to 500 g mL -1 . Samples were diluted into the linear range of the curve using PBS. Samples and standards were equilibrated with filtered Richard Allan Scientific TM alcian blue (88043, Thermo Fisher Scientific) for 2h. The resulting precipitant was separated by centrifugation at 1870 g for 30 min. This was followed by a series of wash/spin cycles at 1870 g in a resuspension buffer composed of 40% ethanol, 0.1 M acetic acid and 25 mM magnesium chloride. The mucin pellets were then dissociated with a 10% SDS solution (71736, Sigma) and absorbance was measure with a microplate reader (Synergy HT, BioTek) at 620 nm. Mucin concentration values for samples were interpolated from a linear fit of the standard curve.
Statistical Analysis
All graphs are depicted as mean ± standard error of the mean (SEM) and significant differences between two groups were determined using two-tailed unpaired Student's t-test. To determine significant differences between 3 groups or more, one-way ANOVA with Tukey's multiple comparisons test was used. With 3 groups or more and 2 independent variables, 2ways ANOVA with Tukey's multiple comparisons was used to determine statistical significance. Prism 7 (GraphPad Software) was used for statistical analysis.
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FIGURE LEGENDS
